PLoS ONE 2011-01-01

Biosynthetic gene cluster for the cladoniamides, bis-indoles with a rearranged scaffold.

Katherine S Ryan

Index: PLoS ONE 6(8) , e23694, (2011)

Full Text: HTML

Abstract

The cladoniamides are bis-indole alkaloids isolated from Streptomyces uncialis, a lichen-associated actinomycete strain. The cladoniamides have an unusual, indenotryptoline structure rarely observed among bis-indole alkaloids. I report here the isolation, sequencing, and annotation of the cladoniamide biosynthetic gene cluster and compare it to the recently published gene cluster for BE-54017, a closely related indenotryptoline natural product. The cladoniamide gene cluster differs from the BE-54017 gene cluster in gene organization and in the absence of one N-methyltransferase gene but otherwise contains close homologs to all genes in the BE-54017 cluster. Both gene clusters encode enzymes needed for the construction of an indolocarbazole core, as well as flavin-dependent enzymes putatively involved in generating the indenotryptoline scaffold from an indolocarbazole. These two bis-indolic gene clusters exemplify the diversity of biosynthetic routes that begin from the oxidative dimerization of two molecules of L-tryptophan, highlight enzymes for further study, and provide new opportunities for combinatorial engineering.


Related Compounds

Related Articles:

Structure and mechanism of the rebeccamycin sugar 4'-O-methyltransferase RebM.

2008-08-15

[J. Biol. Chem. 283(33) , 22628-36, (2008)]

Natural product diversification using a non-natural cofactor analogue of S-adenosyl-L-methionine.

2006-03-08

[J. Am. Chem. Soc. 128(9) , 2760-1, (2006)]

Engineering biosynthetic pathways to generate antitumor indolocarbazole derivatives.

2006-07-01

[J. Ind. Microbiol. Biotechnol. 33(7) , 560-8, (2006)]

Flavin redox chemistry precedes substrate chlorination during the reaction of the flavin-dependent halogenase RebH.

2006-06-27

[Biochemistry 45(25) , 7904-12, (2006)]

Rebeccamycin derivatives as dual DNA-damaging agents and potent checkpoint kinase 1 inhibitors.

2008-12-01

[Mol. Pharmacol. 74(6) , 1620-9, (2008)]

More Articles...